EPS for Medidata Solutions, Inc. (MDSO) Expected At $0.18

January 26, 2018 - By Nellie Frank

 EPS for Medidata Solutions, Inc. (MDSO) Expected At $0.18
Investors sentiment increased to 1.23 in 2017 Q3. Its up 0.06, from 1.17 in 2017Q2. It improved, as 38 investors sold Medidata Solutions, Inc. shares while 60 reduced holdings. 33 funds opened positions while 88 raised stakes. 59.30 million shares or 4.96% more from 56.50 million shares in 2017Q2 were reported.
Polar Cap Ltd Liability Partnership has 262,226 shares for 0.23% of their portfolio. Deutsche Comml Bank Ag owns 252,289 shares or 0.01% of their US portfolio. New York State Common Retirement Fund stated it has 969,531 shares or 0.1% of all its holdings. Prudential Inc owns 0.01% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 61,255 shares. Clearbridge Invests Limited Liability Co stated it has 2.16 million shares. Rhumbline Advisers holds 0.02% or 133,993 shares in its portfolio. Amalgamated Bancorporation stated it has 7,766 shares. Crestpoint Capital Mngmt Limited Liability Corp reported 15,500 shares stake. Great West Life Assurance Com Can holds 34,740 shares or 0.01% of its portfolio. Louisiana State Employees Retirement Sys holds 0.06% in Medidata Solutions, Inc. (NASDAQ:MDSO) or 15,600 shares. Comerica National Bank & Trust holds 51,766 shares or 0.03% of its portfolio. Gru stated it has 157,494 shares. Glenmede Na holds 0% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO) for 1,073 shares. Driehaus Ltd Liability Com holds 45,470 shares or 0.14% of its portfolio. Acadian Asset Management Lc invested 0% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO).

Since August 15, 2017, it had 0 insider buys, and 3 sales for $637,470 activity. Capone Michael L sold $372,650 worth of Medidata Solutions, Inc. (NASDAQ:MDSO) on Tuesday, August 15.

Analysts expect Medidata Solutions, Inc. (NASDAQ:MDSO) to report $0.18 EPS on February, 8.They anticipate $0.05 EPS change or 21.74 % from last quarter’s $0.23 EPS. MDSO’s profit would be $10.53M giving it 97.03 P/E if the $0.18 EPS is correct. After having $0.22 EPS previously, Medidata Solutions, Inc.’s analysts see -18.18 % EPS growth. The stock increased 0.36% or $0.25 during the last trading session, reaching $69.86. About 493,405 shares traded. Medidata Solutions, Inc. (NASDAQ:MDSO) has risen 68.37% since January 26, 2017 and is uptrending. It has outperformed by 51.67% the S&P500.

Medidata Solutions, Inc. (NASDAQ:MDSO) Ratings Coverage

Among 17 analysts covering Medidata Solutions Inc. (NASDAQ:MDSO), 14 have Buy rating, 0 Sell and 3 Hold. Therefore 82% are positive. Medidata Solutions Inc. had 39 analyst reports since July 22, 2015 according to SRatingsIntel. Topeka Capital Markets maintained the stock with “Hold” rating in Friday, September 25 report. Jefferies maintained it with “Hold” rating and $6300 target in Friday, June 16 report. The rating was maintained by SunTrust with “Buy” on Monday, January 22. Wells Fargo maintained Medidata Solutions, Inc. (NASDAQ:MDSO) rating on Friday, October 27. Wells Fargo has “Market Perform” rating and $80 target. The rating was maintained by SunTrust with “Buy” on Friday, October 27. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) earned “Buy” rating by Deutsche Bank on Tuesday, September 13. The rating was maintained by KeyBanc Capital Markets on Sunday, October 22 with “Buy”. Wells Fargo upgraded Medidata Solutions, Inc. (NASDAQ:MDSO) rating on Friday, December 1. Wells Fargo has “Buy” rating and $80.0 target. SunTrust upgraded the stock to “Buy” rating in Friday, February 10 report. The firm has “Hold” rating given on Monday, August 21 by Jefferies.

Medidata Solutions, Inc. provides cloud solutions for life sciences worldwide. The company has market cap of $4.09 billion. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. It has a 99.94 P/E ratio. The companyÂ’s platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments.

More notable recent Medidata Solutions, Inc. (NASDAQ:MDSO) news were published by: Seekingalpha.com which released: “Medidata Solutions’ (MDSO) CEO Tarek Sherif on Q2 2017 Results – Earnings Call …” on July 18, 2017, also Seekingalpha.com with their article: “Medidata Solutions’ (MDSO) CEO Tarek Sherif on Q1 2017 Results – Earnings Call …” published on April 26, 2017, Nasdaq.com published: “Medidata Solutions (MDSO) Set to Join the S&P 400 Index” on June 21, 2017. More interesting news about Medidata Solutions, Inc. (NASDAQ:MDSO) were released by: Seekingalpha.com and their article: “Medidata Solutions’ (MDSO) CEO Tarek Sherif on Q3 2017 Results – Earnings Call …” published on October 26, 2017 as well as Law360.com‘s news article titled: “Medidata Covered For $4.8M Computer Fraud, Judge Rules” with publication date: July 22, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: